Well ResearchedInjectable
CJC-1295 with DAC
CJC-1295 with Drug Affinity Complex
Dose
1-2mg
Frequency
1-2x weekly
Cycle
8-12 weeks
Storage
Refrigerated 2-8°C
Overview
CJC-1295 with DAC is a synthetic analog of growth hormone releasing hormone (GHRH). The Drug Affinity Complex extends its half-life significantly, allowing for less frequent dosing while maintaining elevated GH levels.
Molecular Information
Molecular Weight
3647.28 g/mol
Formula
C165H269N47O46
CAS Number
863288-34-0
Research Indications
- Sustained GH Elevation
- IGF-1 Optimization
- Convenience Protocol
- Fat Loss Enhancement
- Lean Mass Gains
Research Protocols
| Phase | Dose | Frequency | Duration | Notes |
|---|---|---|---|---|
| Standard | 2mg | 1x weekly | 8-12 weeks | Subcutaneous administration |
| Enhanced | 2mg | 2x weekly | 8-12 weeks | For more aggressive protocols |
Interactions
- Can be used alongside Ipamorelin
- No known significant drug interactions
- May enhance effects of exercise on body composition
How to Reconstitute
Reconstitute with bacteriostatic water. Add 2mL per 2mg vial. Store refrigerated.
Quality Indicators
Long Half-Life
8+ day duration of action
Convenience
Weekly dosing possible
Consistent Levels
Less pulsatile than natural GH
What to Expect
1
Week 1-2: Improved sleep and recovery beginning
2
Week 4-6: Noticeable body composition changes
3
Week 8-12: Significant fat loss and lean mass improvements
Side Effects & Safety
- Possible water retention
- Injection site reactions
- Numbness or tingling
- Fatigue initially